Insulet acquires Bigfoot’s insulin pump patents for $25M
The Omnipod maker purchased assets related to Bigfoot Biomedical’s pump-based automated insulin delivery technology.
The Omnipod maker purchased assets related to Bigfoot Biomedical’s pump-based automated insulin delivery technology.
Go to Source
2023-02-14 00:50
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
